Valuation
- Market cap
- 26,079,000
- Revenue TTM
- $7,770,000
- Net income TTM
- $-11,780,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -151.61%
- Debt to equity
- -1.38
Trading
- Volume
- 141,600
- Avg volume
- 393,682
- Day's range
- $0.08 – $0.08
- Shares out
- 332,221,000
- Stochastic %K
- 17%
- Beta
- -0.11
- Analysts
- Strong Buy
- Price target
- $0.36
Company profile
BioLargo, Inc. invents, develops, and commercializes various platform technologies in the United States. The company's technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances (PFAS) water contamination; advanced water and wastewater treatment; industrial odor and volatile organic compounds control, air quality control, and infection control; and myriad environmental remedi...
Show more
BioLargo, Inc. invents, develops, and commercializes various platform technologies in the United States. The company's technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances (PFAS) water contamination; advanced water and wastewater treatment; industrial odor and volatile organic compounds control, air quality control, and infection control; and myriad environmental remediation. It provides full-service environmental engineering, battery energy storage, and advanced antimicrobial medical device platforms. BioLargo, Inc. is based in Westminster, California.
- Industry
- Specialty Chemicals
- Sector
- Basic Materials
- Phone
- 888 400 2863
- Website
- https://www.biolargo.com
- Address
- 14921 Chestnut Street, Westminster, United States
Latest news
No headlines yet.
